159 related articles for article (PubMed ID: 8192530)
1. Recombinant human erythropoietin administration improves thiamine content in blood and erythrocytes transketolase activity in pre-dialyzed patients.
Pietrzak I; Baczyk K; Kubiak W
Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():29-37. PubMed ID: 8192530
[TBL] [Abstract][Full Text] [Related]
2. [The effect of cocarboxylase treatment on erythrocyte transketolase and blood thiamine in patients with end stage renal disease undergoing maintenance hemodialysis].
Pietrzak I; Czarnecki R; Baczyk K; Młynarczyk M; Kaczmarek M
Przegl Lek; 2000; 57(7-8):369-73. PubMed ID: 11109306
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the thiamine level in blood and erythrocyte transketolase activity in hemodialyzed and nondialyzed patients during recombinant human erythropoietin therapy.
Pietrzak I; Baczyk K
Miner Electrolyte Metab; 1997; 23(3-6):277-82. PubMed ID: 9387133
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal dialysis adequacy during the r-Hu EPO treatment.
Baranowska-Daca E; Ksiazek A
Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():51-60. PubMed ID: 8192532
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin improves enzyme activity in erythrocytes of predialysis uremics.
Pietrzak I; Baczyk K; Kubiak W
Miner Electrolyte Metab; 1996; 22(1-3):102-5. PubMed ID: 8676797
[TBL] [Abstract][Full Text] [Related]
6. The effect of recombinant human erythropoietin (r-Hu EPO) administration on the blood chemistries and composition in uremic rats.
Kozioł M; Ksiazek P; Feldo M; Spasiewicz D; Michalak J; Kleinrok Z
Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():61-6. PubMed ID: 8192533
[TBL] [Abstract][Full Text] [Related]
7. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
[TBL] [Abstract][Full Text] [Related]
8. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
[TBL] [Abstract][Full Text] [Related]
9. [Chemical structure, biotechnical production and clinical use of recombinant erythropoietin].
Fandrey JK; Jelkmann WE
Z Gesamte Inn Med; 1992 Jun; 47(6):231-8. PubMed ID: 1642021
[TBL] [Abstract][Full Text] [Related]
10. r.hu-erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline.
Tapolyai M; Kadomatsu S; Perera-Chong M
BMC Nephrol; 2003 Jun; 4():3. PubMed ID: 12809563
[TBL] [Abstract][Full Text] [Related]
11. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
Monnerat C; Leyvraz S
Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
[TBL] [Abstract][Full Text] [Related]
12. The effect of subcutaneous recombinant human erythropoietin (r-Hu EPO) in CAPD patients with renal anaemia.
Janicka L; Ksiazek A; Baranowicz I; Mierzicki P
Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():67-77. PubMed ID: 8192534
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the thiamine nutritional status. An evaluation of erythrocyte transketolase activity, the stimulated erythrocyte transketolase activity, and the thiamine pyrophosphate effect.
Graudal N; Torp-Pedersen K; Hanel H; Kristensen M; Thomsen AC; Nørgård G
Int J Vitam Nutr Res; 1985; 55(4):399-403. PubMed ID: 4086209
[TBL] [Abstract][Full Text] [Related]
14. [The effect of recombinant erythropoietin on candidicidal activity of polymorphonuclear leukocytes in hemodialyzed patients].
Bartůnková J; Sulková S; Cebecauer M
Cas Lek Cesk; 1995 Dec; 134(23):756-9. PubMed ID: 8599817
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of anemia in chronic renal failure (predialysis)].
Ruedin P
Praxis (Bern 1994); 1999 Jan; 88(5):173-7. PubMed ID: 10067374
[TBL] [Abstract][Full Text] [Related]
16. Influence of long-term erythropoietin treatment on plasma levels of calcium-phosphate related hormones in haemodialyzed uraemic patients.
Kokot F; Wiecek A; Marcinkowski W; Schmidt-Gayk H; Rudka R; Trembecki J
Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():9-16. PubMed ID: 8192535
[TBL] [Abstract][Full Text] [Related]
17. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of platelet function during treatment with recombinant human erythropoietin (r-HuEPO) in patients hemodialyzed and dialyzed peritoneally].
Janicka L; Majdan M; Dmoszyńska A; Ksiazek A; Berger B; Baranowska E
Wiad Lek; 1993 Oct; 46(19-20):756-60. PubMed ID: 7975620
[TBL] [Abstract][Full Text] [Related]
19. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
[TBL] [Abstract][Full Text] [Related]
20. [Endogenous erythropoietin in patients on regular dialysis therapy].
Zadrazil J; Bachleda P; Zahálková J
Vnitr Lek; 1997 Oct; 43(10):649-54. PubMed ID: 9601878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
